research in targeted cancer therapies
The experimentation process implies a long and slow procedure . Of trial and error, of repeating and insisting, but not giving up. This is how Gabriela works on her thesis topic , with patience and discipline.
She explains that the current treatment of pancreatic cancer is usually palliative. Depending on the stage, chemotherapy, radiotherapy or immunotherapy is applied, although with modest results. Gabriela is researching new strategies to improve the efficacy of targeted cancer therapies. She uses a tool based on CRISPR-Cas9 technology, which allows very precise DNA editing. Using this system, she silences thousands of different genes in mouse models of pancreatic cancer in order to identify which of them make the tumors more sensitive to certain treatments.
In his work, he uses what he calls abookshop Genetics": a set of modified tumor cells, each with a different gene inactivated. CRISPR works like a molecular scalpel," he explains. If you give it a guide, it looks for the exact DNA sequence that matches it, cuts it and causes what we call a knockout, i.e., gene silencing. Thanks to this strategy, it is possible to detect which genes, when eliminated, make the cells respond better to targeted therapies, opening the door to new, more effective treatment combinations.